Area of research
Molecular Biology · Surgery
Research interest
Research interests include DNA Repair Mechanisms, Epigenetics and DNA Methylation, Cholangiocarcinoma and Gallbladder Cancer Studies, and Cancer-related Molecular Pathways.
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.